FindMyKOL

Darren McGuire, MD

Enriched profile

Distinguished Teaching Professor · University of Texas Southwestern Medical School

ORCID↗NPI↗
✓ Itemized profile
Region🇺🇸 Dallas, TX · South Central · United StatesSpecialtyCardiovascular DiseaseFocusDiabetes Treatment and Management+4
Active KOLFindMyKOL type: NationalLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding2005–2007

Darren McGuire is Distinguished Teaching Professor at University of Texas Southwestern Medical School. OpenAlex indexes 755 publications with 109,965 citations (h-index 117); ClinicalTrials.gov lists 1 registered study with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Cardiovascular Disease profiles in the FindMyKOL directory.

Data verified 13 Nov 2026

Overview

Updated 17 Nov 2026

Darren McGuire, MD, is Distinguished Teaching Professor at University of Texas Southwestern Medical School. The public record shows 755 publications with 109,965 citations (h-index 117), centered on Diabetes Treatment and Management, Diabetes, Cardiovascular Risks, and Lipoproteins, Heart Failure Treatment and Management. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 33 companies, 1 NIH-funded awards (2005–2007).

  • Most recent indexed publication: 2026 · European heart journal. Cardiovascular pharmacotherapy
  • Top research focus: Diabetes Treatment and Management
  • 1 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 33 companies

Generated from the cited public record · current as of 17 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Type 2 Diabetes1 trialDiabetes Mellitus1 trialAtrial FibrillationChronic Kidney DiseaseCOPDCoronary Artery Disease / ACSCOVID-19Diabetic ComplicationsDyslipidemia / Lipid DisordersESRD / DialysisGoutHeart FailureHypertensionObesityOsteoporosisStrokeSubstance Use Disorders

Research focus

OpenAlex concept fingerprint
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and LipoproteinsHeart Failure Treatment and ManagementDiabetes Management and ResearchChronic Kidney Disease and Diabetes

Drugs & molecules

across trials, industry payments and publications
Jardiancegeneric · EmpagliflozinClinical trials—Industry payments29Publications1Farxigageneric · DapagliflozinClinical trials—Industry payments13Publications11Mounjarogeneric · TirzepatideClinical trials—Industry payments11Publications3Victozageneric · LiraglutideClinical trials—Industry payments6Publications1Steglatrogeneric · ErtugliflozinClinical trials—Industry payments2Publications4Tradjentageneric · LinagliptinClinical trials—Industry payments3Publications2Kerendiageneric · FinerenoneClinical trials—Industry payments2Publications1Nexletolgeneric · Bempedoic acidClinical trials—Industry payments5Publications—Heplisav-Bgeneric · Hepatitis B surface antigen vaccineClinical trials—Industry payments4Publications—Tryviogeneric · AprocitentanClinical trials—Industry payments2Publications—Leqviogeneric · InclisiranClinical trials—Industry payments1Publications—Omega-3 carboxylic acidsClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Eli Lilly and CompanyClinical trials—Industry payments76Novo Nordisk ASClinical trials—Industry payments34Boehringer Ingelheim International GmbHClinical trials—Industry payments32Novo Nordisk IncClinical trials—Industry payments28Boehringer Ingelheim Pharmaceuticals, Inc.Clinical trials—Industry payments23AstraZeneca UK LimitedClinical trials—Industry payments14Lexicon Pharmaceuticals, Inc.Clinical trials—Industry payments12Pfizer Inc.Clinical trials—Industry payments12CSL BehringClinical trials—Industry payments11Amgen Inc.Clinical trials—Industry payments9Esperion Therapeutics, Inc.Clinical trials—Industry payments5Intercept Pharmaceuticals, Inc.Clinical trials—Industry payments5Dynavax Technologies CorporationClinical trials—Industry payments4Boehringer Ingelheim MENA (Scientific Office) FZ-LLCClinical trials—Industry payments3Otsuka Pharmaceutical Development & Commercialization, Inc.Clinical trials—Industry payments3Abbvie Inc.Clinical trials—Industry payments2Bayer HealthCare Pharmaceuticals Inc.Clinical trials—Industry payments2Boehringer Ingelheim Mexico SA de CVClinical trials—Industry payments2Idorsia Pharmaceuticals Us IncClinical trials—Industry payments2Medtronic, Inc.Clinical trials—Industry payments2Alnylam Pharmaceuticals Inc.Clinical trials—Industry payments1AltaThera Pharmaceuticals LLCClinical trials—Industry payments1AstraZeneca Pharmaceuticals LPClinical trials—Industry payments1Boehringer Ingelheim India Pvt. Ltd.Clinical trials—Industry payments1Boehringer Ingelheim Singapore Pte. Ltd.Clinical trials—Industry payments1F. Hoffmann-La Roche AGClinical trials—Industry payments1GlaxoSmithKline, LLC.Clinical trials—Industry payments1Ipsen Bioscience IncClinical trials—Industry payments1Merck Sharp & Dohme CorporationClinical trials—Industry payments1Novartis Pharmaceuticals CorporationClinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
755publications

Publications indexed by OpenAlex, matched via ORCID. 66 in PubMed. Counts exclude supporting files.

109,965citations

Citations across these publications.

117h-index

H-index from these publications. i10-index 397.

Clinical & industry

trials, payments and federal funding
1clinical trials

Investigator role on registered studies.

View trials ↓
33companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
1NIH grants · 2005–2007

Federally funded research awards.

View funding ↓

Public positions

sourced statements on record
  • Ad hoc consultant

    FDA Cardiovascular and Renal Drugs Advisory Committee

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →utswmed.org ↗

Contact

No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →

Clinical trials

Updated 13 Nov 2026

Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:

Industry payments

Updated 13 Nov 2026

33 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2022)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    100%
    Beta blocker34.4%
    Carvedilol100%
    Part D<11 patients
    Statin28.1%
    Atorvastatin Calcium100%
    Part D≥11 patients

    + 2 more classes in this area

Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 13 Nov 2026

1 NIH research award on record, funded 2005–2007 per NIH RePORTER. The latest:

Congress activity

Updated 13 Nov 2026

84 congress contributions (2018–2026) across ADA, AHA, ASN, ENDO, ESC, IDSA per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 13 Nov 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 13 Nov 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • ResearchGate

    researchgate.net/profile/Darren-Mcguire

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Other

    cardiometabolichealth.org/faculty/darren-mcguire

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiometabolichealth.org ↗
  • X / Twitter

    Sandeep Das (@sandeepdasmd) on X congratulates Darren McGuire and colleagues on an updated SGLT2 inhibitor meta-analysis in JAMA Cardiology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 13 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • Master of Health Sciences

    Duke University School of Medicine

    2001
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →cardiometabolichealth.org ↗
  • MD

    Johns Hopkins University School of Medicine

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗

Awards & honors

honors on the public record

Secondary affiliations

appointments beyond the home institution
  • Lead Physician

    Parkland Health Outpatient Cardiology Clinic

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →profiles.utsouthwestern.edu ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.